Cyclo Therapeutics, Inc. (CYTHW) 은(는) 상장 기업입니다 헬스케어 섹터의 Drug Manufacturers - Specialty & Generic 산업에서 운영. 본사 소재지는 Gainesville, FL, 미국. 현재 CEO는 N. Scott Fine.
CYTHW 을(를) 보유 IPO 날짜 2020-12-18, 8 명의 정규직 직원, 에 상장 NASDAQ Capital Marke, 시가총액 $899.37K.
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
